Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
280280 ratings
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
323 Listeners
Practical Neurology Podcast
48 Listeners
JAMA Clinical Reviews
500 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,138 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
192 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
133 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Neurology Exam Prep Podcast
185 Listeners
The Curious Clinicians
374 Listeners
Continuum Audio
81 Listeners